When to screen for lupus anticoagulant? Influence of testing during acute phase and consequences for clinical practise.
Department of Clinical Chemistry and Haematology, Rijnstate Hospital, The Netherlands jruinemans-koerts@rijnstate.nl.
J
J
Ruinemans-Koerts
Department of Internal Medicine, Rijnstate Hospital, The Netherlands.
Y M
YM
Ahmed-Ousenkova
Department of Internal Medicine, Rijnstate Hospital, The Netherlands.
H A H
HA
Kaasjager
Department of Clinical Chemistry and Haematology, Rijnstate Hospital, The Netherlands.
C
C
Hendriks-van Wijhe
Department of Internal Medicine, Rijnstate Hospital, The Netherlands.
M M C
MM
Hovens
D000210:Acute-Phase Reaction / Q000097:blood; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017152:Antibodies, Antiphospholipid / Q000032:analysis; D016736:Antiphospholipid Syndrome / Q000097:blood* / Q000175:diagnosis; D005260:Female; D006801:Humans; D059021:Laboratory Proficiency Testing; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008297:Male; D008403:Mass Screening / Q000379:methods; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D013927:Thrombosis / Q000097:blood
D017152:Antibodies, Antiphospholipid; D016682:Lupus Coagulation Inhibitor